nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Cloperastine—Raloxifene—breast cancer	0.228	0.286	CrCrCtD
Dimenhydrinate—Bromodiphenhydramine—Toremifene—breast cancer	0.141	0.177	CrCrCtD
Dimenhydrinate—Orphenadrine—Toremifene—breast cancer	0.11	0.139	CrCrCtD
Dimenhydrinate—Diphenhydramine—Toremifene—breast cancer	0.0981	0.123	CrCrCtD
Dimenhydrinate—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0883	0.111	CrCrCtD
Dimenhydrinate—Orphenadrine—Tamoxifen—breast cancer	0.0694	0.0871	CrCrCtD
Dimenhydrinate—Diphenhydramine—Tamoxifen—breast cancer	0.0616	0.0774	CrCrCtD
Dimenhydrinate—Orphenadrine—SCN10A—breast cancer	0.000237	0.323	CrCbGaD
Dimenhydrinate—Vomiting—Goserelin—breast cancer	0.000206	0.00103	CcSEcCtD
Dimenhydrinate—Paraesthesia—Fluorouracil—breast cancer	0.000205	0.00103	CcSEcCtD
Dimenhydrinate—Constipation—Mitoxantrone—breast cancer	0.000204	0.00102	CcSEcCtD
Dimenhydrinate—Constipation—Irinotecan—breast cancer	0.000204	0.00102	CcSEcCtD
Dimenhydrinate—Rash—Goserelin—breast cancer	0.000204	0.00102	CcSEcCtD
Dimenhydrinate—Dermatitis—Goserelin—breast cancer	0.000204	0.00102	CcSEcCtD
Dimenhydrinate—Somnolence—Fluorouracil—breast cancer	0.000203	0.00102	CcSEcCtD
Dimenhydrinate—Headache—Goserelin—breast cancer	0.000203	0.00101	CcSEcCtD
Dimenhydrinate—Decreased appetite—Gemcitabine—breast cancer	0.000202	0.00101	CcSEcCtD
Dimenhydrinate—Chills—Capecitabine—breast cancer	0.000202	0.00101	CcSEcCtD
Dimenhydrinate—Dyspepsia—Fluorouracil—breast cancer	0.000201	0.00101	CcSEcCtD
Dimenhydrinate—Nausea—Tamoxifen—breast cancer	0.000201	0.00101	CcSEcCtD
Dimenhydrinate—Fatigue—Gemcitabine—breast cancer	0.000201	0.001	CcSEcCtD
Dimenhydrinate—Constipation—Gemcitabine—breast cancer	0.000199	0.000997	CcSEcCtD
Dimenhydrinate—Decreased appetite—Fluorouracil—breast cancer	0.000199	0.000996	CcSEcCtD
Dimenhydrinate—Dry mouth—Paclitaxel—breast cancer	0.000199	0.000995	CcSEcCtD
Dimenhydrinate—Asthenia—Thiotepa—breast cancer	0.000198	0.000994	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vinorelbine—breast cancer	0.000198	0.000992	CcSEcCtD
Dimenhydrinate—Nausea—Melphalan—breast cancer	0.000197	0.000986	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Irinotecan—breast cancer	0.000197	0.000986	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Mitoxantrone—breast cancer	0.000197	0.000986	CcSEcCtD
Dimenhydrinate—Confusional state—Paclitaxel—breast cancer	0.000196	0.000984	CcSEcCtD
Dimenhydrinate—Dysuria—Methotrexate—breast cancer	0.000196	0.00098	CcSEcCtD
Dimenhydrinate—Nausea—Goserelin—breast cancer	0.000192	0.000962	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Gemcitabine—breast cancer	0.000192	0.00096	CcSEcCtD
Dimenhydrinate—Dizziness—Vinorelbine—breast cancer	0.000191	0.000959	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Methotrexate—breast cancer	0.000191	0.000957	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Paclitaxel—breast cancer	0.000191	0.000955	CcSEcCtD
Dimenhydrinate—Tachycardia—Paclitaxel—breast cancer	0.00019	0.000952	CcSEcCtD
Dimenhydrinate—Urticaria—Mitoxantrone—breast cancer	0.00019	0.00095	CcSEcCtD
Dimenhydrinate—Diarrhoea—Thiotepa—breast cancer	0.000189	0.000948	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Fluorouracil—breast cancer	0.000188	0.000944	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Paclitaxel—breast cancer	0.000188	0.000943	CcSEcCtD
Dimenhydrinate—Drowsiness—Methotrexate—breast cancer	0.000187	0.000935	CcSEcCtD
Dimenhydrinate—Anorexia—Paclitaxel—breast cancer	0.000186	0.00093	CcSEcCtD
Dimenhydrinate—Vision blurred—Capecitabine—breast cancer	0.000185	0.000925	CcSEcCtD
Dimenhydrinate—Vomiting—Vinorelbine—breast cancer	0.000184	0.000922	CcSEcCtD
Dimenhydrinate—Tremor—Capecitabine—breast cancer	0.000183	0.000919	CcSEcCtD
Dimenhydrinate—Dysuria—Epirubicin—breast cancer	0.000183	0.000917	CcSEcCtD
Dimenhydrinate—Dizziness—Thiotepa—breast cancer	0.000183	0.000916	CcSEcCtD
Dimenhydrinate—Rash—Vinorelbine—breast cancer	0.000183	0.000915	CcSEcCtD
Dimenhydrinate—Dermatitis—Vinorelbine—breast cancer	0.000182	0.000914	CcSEcCtD
Dimenhydrinate—Hypotension—Paclitaxel—breast cancer	0.000182	0.000912	CcSEcCtD
Dimenhydrinate—Urticaria—Fluorouracil—breast cancer	0.000182	0.00091	CcSEcCtD
Dimenhydrinate—Headache—Vinorelbine—breast cancer	0.000181	0.000909	CcSEcCtD
Dimenhydrinate—Pollakiuria—Epirubicin—breast cancer	0.000181	0.000906	CcSEcCtD
Dimenhydrinate—Palpitations—Docetaxel—breast cancer	0.000179	0.000895	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Epirubicin—breast cancer	0.000179	0.000895	CcSEcCtD
Dimenhydrinate—Insomnia—Paclitaxel—breast cancer	0.000176	0.000882	CcSEcCtD
Dimenhydrinate—Vertigo—Capecitabine—breast cancer	0.000176	0.000881	CcSEcCtD
Dimenhydrinate—Vomiting—Thiotepa—breast cancer	0.000176	0.000881	CcSEcCtD
Dimenhydrinate—Convulsion—Docetaxel—breast cancer	0.000175	0.000878	CcSEcCtD
Dimenhydrinate—Paraesthesia—Paclitaxel—breast cancer	0.000175	0.000876	CcSEcCtD
Dimenhydrinate—Drowsiness—Epirubicin—breast cancer	0.000175	0.000875	CcSEcCtD
Dimenhydrinate—Rash—Thiotepa—breast cancer	0.000174	0.000873	CcSEcCtD
Dimenhydrinate—Dermatitis—Thiotepa—breast cancer	0.000174	0.000873	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Methotrexate—breast cancer	0.000174	0.000872	CcSEcCtD
Dimenhydrinate—Headache—Thiotepa—breast cancer	0.000173	0.000868	CcSEcCtD
Dimenhydrinate—Somnolence—Paclitaxel—breast cancer	0.000173	0.000867	CcSEcCtD
Dimenhydrinate—Palpitations—Capecitabine—breast cancer	0.000173	0.000867	CcSEcCtD
Dimenhydrinate—Nausea—Vinorelbine—breast cancer	0.000172	0.000862	CcSEcCtD
Dimenhydrinate—Dyspepsia—Paclitaxel—breast cancer	0.000171	0.000859	CcSEcCtD
Dimenhydrinate—Asthenia—Irinotecan—breast cancer	0.000171	0.000858	CcSEcCtD
Dimenhydrinate—Asthenia—Mitoxantrone—breast cancer	0.000171	0.000858	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Epirubicin—breast cancer	0.000171	0.000857	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—breast cancer	0.000169	0.000849	CcSEcCtD
Dimenhydrinate—Decreased appetite—Paclitaxel—breast cancer	0.000169	0.000848	CcSEcCtD
Dimenhydrinate—Dry mouth—Docetaxel—breast cancer	0.000168	0.000844	CcSEcCtD
Dimenhydrinate—Fatigue—Paclitaxel—breast cancer	0.000168	0.000841	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—breast cancer	0.000167	0.000838	CcSEcCtD
Dimenhydrinate—Asthenia—Gemcitabine—breast cancer	0.000167	0.000836	CcSEcCtD
Dimenhydrinate—Constipation—Paclitaxel—breast cancer	0.000167	0.000834	CcSEcCtD
Dimenhydrinate—Confusional state—Docetaxel—breast cancer	0.000166	0.000834	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—breast cancer	0.000165	0.000828	CcSEcCtD
Dimenhydrinate—Nausea—Thiotepa—breast cancer	0.000164	0.000823	CcSEcCtD
Dimenhydrinate—Diarrhoea—Mitoxantrone—breast cancer	0.000163	0.000819	CcSEcCtD
Dimenhydrinate—Diarrhoea—Irinotecan—breast cancer	0.000163	0.000819	CcSEcCtD
Dimenhydrinate—Dry mouth—Capecitabine—breast cancer	0.000163	0.000817	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Epirubicin—breast cancer	0.000163	0.000816	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Docetaxel—breast cancer	0.000162	0.00081	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—breast cancer	0.000162	0.000809	CcSEcCtD
Dimenhydrinate—Confusional state—Capecitabine—breast cancer	0.000161	0.000807	CcSEcCtD
Dimenhydrinate—Tachycardia—Docetaxel—breast cancer	0.000161	0.000807	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Paclitaxel—breast cancer	0.00016	0.000804	CcSEcCtD
Dimenhydrinate—Diarrhoea—Gemcitabine—breast cancer	0.000159	0.000797	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—breast cancer	0.000158	0.000793	CcSEcCtD
Dimenhydrinate—Dizziness—Irinotecan—breast cancer	0.000158	0.000791	CcSEcCtD
Dimenhydrinate—Anorexia—Docetaxel—breast cancer	0.000157	0.000788	CcSEcCtD
Dimenhydrinate—Diarrhoea—Fluorouracil—breast cancer	0.000156	0.000784	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Capecitabine—breast cancer	0.000156	0.000784	CcSEcCtD
Dimenhydrinate—Tinnitus—Methotrexate—breast cancer	0.000156	0.000782	CcSEcCtD
Dimenhydrinate—Tachycardia—Capecitabine—breast cancer	0.000156	0.000781	CcSEcCtD
Dimenhydrinate—Urticaria—Paclitaxel—breast cancer	0.000155	0.000775	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Capecitabine—breast cancer	0.000155	0.000774	CcSEcCtD
Dimenhydrinate—Hypotension—Docetaxel—breast cancer	0.000154	0.000773	CcSEcCtD
Dimenhydrinate—Anorexia—Capecitabine—breast cancer	0.000152	0.000763	CcSEcCtD
Dimenhydrinate—Vomiting—Irinotecan—breast cancer	0.000152	0.000761	CcSEcCtD
Dimenhydrinate—Vomiting—Mitoxantrone—breast cancer	0.000152	0.000761	CcSEcCtD
Dimenhydrinate—Dizziness—Fluorouracil—breast cancer	0.000151	0.000758	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—breast cancer	0.000151	0.000755	CcSEcCtD
Dimenhydrinate—Rash—Mitoxantrone—breast cancer	0.000151	0.000754	CcSEcCtD
Dimenhydrinate—Rash—Irinotecan—breast cancer	0.000151	0.000754	CcSEcCtD
Dimenhydrinate—Dermatitis—Irinotecan—breast cancer	0.00015	0.000754	CcSEcCtD
Dimenhydrinate—Dermatitis—Mitoxantrone—breast cancer	0.00015	0.000754	CcSEcCtD
Dimenhydrinate—Chills—Methotrexate—breast cancer	0.00015	0.000753	CcSEcCtD
Dimenhydrinate—Headache—Mitoxantrone—breast cancer	0.00015	0.000749	CcSEcCtD
Dimenhydrinate—Headache—Irinotecan—breast cancer	0.00015	0.000749	CcSEcCtD
Dimenhydrinate—Benzatropine—CYP2D6—breast cancer	0.000149	0.204	CrCbGaD
Dimenhydrinate—Hypotension—Capecitabine—breast cancer	0.000149	0.000748	CcSEcCtD
Dimenhydrinate—Insomnia—Docetaxel—breast cancer	0.000149	0.000748	CcSEcCtD
Dimenhydrinate—Paraesthesia—Docetaxel—breast cancer	0.000148	0.000743	CcSEcCtD
Dimenhydrinate—Vomiting—Gemcitabine—breast cancer	0.000148	0.000741	CcSEcCtD
Dimenhydrinate—Somnolence—Docetaxel—breast cancer	0.000147	0.000735	CcSEcCtD
Dimenhydrinate—Rash—Gemcitabine—breast cancer	0.000147	0.000735	CcSEcCtD
Dimenhydrinate—Dermatitis—Gemcitabine—breast cancer	0.000147	0.000734	CcSEcCtD
Dimenhydrinate—Tinnitus—Epirubicin—breast cancer	0.000146	0.000732	CcSEcCtD
Dimenhydrinate—Headache—Gemcitabine—breast cancer	0.000146	0.00073	CcSEcCtD
Dimenhydrinate—Vomiting—Fluorouracil—breast cancer	0.000145	0.000729	CcSEcCtD
Dimenhydrinate—Dyspepsia—Docetaxel—breast cancer	0.000145	0.000728	CcSEcCtD
Dimenhydrinate—Insomnia—Capecitabine—breast cancer	0.000145	0.000724	CcSEcCtD
Dimenhydrinate—Rash—Fluorouracil—breast cancer	0.000144	0.000722	CcSEcCtD
Dimenhydrinate—Dermatitis—Fluorouracil—breast cancer	0.000144	0.000722	CcSEcCtD
Dimenhydrinate—Paraesthesia—Capecitabine—breast cancer	0.000144	0.000719	CcSEcCtD
Dimenhydrinate—Decreased appetite—Docetaxel—breast cancer	0.000143	0.000719	CcSEcCtD
Dimenhydrinate—Headache—Fluorouracil—breast cancer	0.000143	0.000718	CcSEcCtD
Dimenhydrinate—Fatigue—Docetaxel—breast cancer	0.000142	0.000713	CcSEcCtD
Dimenhydrinate—Nausea—Mitoxantrone—breast cancer	0.000142	0.000711	CcSEcCtD
Dimenhydrinate—Nausea—Irinotecan—breast cancer	0.000142	0.000711	CcSEcCtD
Dimenhydrinate—Constipation—Docetaxel—breast cancer	0.000141	0.000707	CcSEcCtD
Dimenhydrinate—Dyspepsia—Capecitabine—breast cancer	0.000141	0.000705	CcSEcCtD
Dimenhydrinate—Chills—Epirubicin—breast cancer	0.000141	0.000704	CcSEcCtD
Dimenhydrinate—Asthenia—Paclitaxel—breast cancer	0.00014	0.0007	CcSEcCtD
Dimenhydrinate—Decreased appetite—Capecitabine—breast cancer	0.000139	0.000696	CcSEcCtD
Dimenhydrinate—Nausea—Gemcitabine—breast cancer	0.000138	0.000692	CcSEcCtD
Dimenhydrinate—Fatigue—Capecitabine—breast cancer	0.000138	0.00069	CcSEcCtD
Dimenhydrinate—Vision blurred—Methotrexate—breast cancer	0.000137	0.000688	CcSEcCtD
Dimenhydrinate—Constipation—Capecitabine—breast cancer	0.000137	0.000685	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Docetaxel—breast cancer	0.000136	0.000681	CcSEcCtD
Dimenhydrinate—Nausea—Fluorouracil—breast cancer	0.000136	0.000681	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—breast cancer	0.000135	0.000677	CcSEcCtD
Dimenhydrinate—Tension—Epirubicin—breast cancer	0.000134	0.000671	CcSEcCtD
Dimenhydrinate—Diarrhoea—Paclitaxel—breast cancer	0.000133	0.000668	CcSEcCtD
Dimenhydrinate—Nervousness—Epirubicin—breast cancer	0.000133	0.000664	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Capecitabine—breast cancer	0.000132	0.00066	CcSEcCtD
Dimenhydrinate—Vertigo—Methotrexate—breast cancer	0.000131	0.000656	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—breast cancer	0.00013	0.000652	CcSEcCtD
Dimenhydrinate—Dizziness—Paclitaxel—breast cancer	0.000129	0.000645	CcSEcCtD
Dimenhydrinate—Vision blurred—Epirubicin—breast cancer	0.000129	0.000644	CcSEcCtD
Dimenhydrinate—Urticaria—Capecitabine—breast cancer	0.000127	0.000636	CcSEcCtD
Dimenhydrinate—Convulsion—Methotrexate—breast cancer	0.000126	0.000633	CcSEcCtD
Dimenhydrinate—Agitation—Epirubicin—breast cancer	0.000125	0.000628	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—breast cancer	0.000124	0.000621	CcSEcCtD
Dimenhydrinate—Vomiting—Paclitaxel—breast cancer	0.000124	0.00062	CcSEcCtD
Dimenhydrinate—Rash—Paclitaxel—breast cancer	0.000123	0.000615	CcSEcCtD
Dimenhydrinate—Dermatitis—Paclitaxel—breast cancer	0.000123	0.000615	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—breast cancer	0.000123	0.000614	CcSEcCtD
Dimenhydrinate—Vertigo—Epirubicin—breast cancer	0.000123	0.000614	CcSEcCtD
Dimenhydrinate—Headache—Paclitaxel—breast cancer	0.000122	0.000611	CcSEcCtD
Dimenhydrinate—Palpitations—Epirubicin—breast cancer	0.000121	0.000604	CcSEcCtD
Dimenhydrinate—Confusional state—Methotrexate—breast cancer	0.00012	0.000601	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—breast cancer	0.000119	0.000596	CcSEcCtD
Dimenhydrinate—Asthenia—Docetaxel—breast cancer	0.000118	0.000593	CcSEcCtD
Dimenhydrinate—Convulsion—Epirubicin—breast cancer	0.000118	0.000592	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Methotrexate—breast cancer	0.000116	0.000584	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—breast cancer	0.000116	0.000581	CcSEcCtD
Dimenhydrinate—Nausea—Paclitaxel—breast cancer	0.000116	0.00058	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Methotrexate—breast cancer	0.000115	0.000576	CcSEcCtD
Dimenhydrinate—Asthenia—Capecitabine—breast cancer	0.000115	0.000574	CcSEcCtD
Dimenhydrinate—Dry mouth—Epirubicin—breast cancer	0.000114	0.000569	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—breast cancer	0.000113	0.000568	CcSEcCtD
Dimenhydrinate—Anorexia—Methotrexate—breast cancer	0.000113	0.000568	CcSEcCtD
Dimenhydrinate—Diarrhoea—Docetaxel—breast cancer	0.000113	0.000566	CcSEcCtD
Dimenhydrinate—Diphenhydramine—PTGS1—breast cancer	0.000113	0.154	CrCbGaD
Dimenhydrinate—Confusional state—Epirubicin—breast cancer	0.000112	0.000562	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—breast cancer	0.000112	0.000559	CcSEcCtD
Dimenhydrinate—Hypotension—Methotrexate—breast cancer	0.000111	0.000557	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—breast cancer	0.000109	0.000548	CcSEcCtD
Dimenhydrinate—Diarrhoea—Capecitabine—breast cancer	0.000109	0.000548	CcSEcCtD
Dimenhydrinate—Dizziness—Docetaxel—breast cancer	0.000109	0.000547	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Epirubicin—breast cancer	0.000109	0.000546	CcSEcCtD
Dimenhydrinate—Tachycardia—Epirubicin—breast cancer	0.000109	0.000544	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Epirubicin—breast cancer	0.000108	0.000539	CcSEcCtD
Dimenhydrinate—Insomnia—Methotrexate—breast cancer	0.000108	0.000539	CcSEcCtD
Dimenhydrinate—Paraesthesia—Methotrexate—breast cancer	0.000107	0.000535	CcSEcCtD
Dimenhydrinate—Anorexia—Epirubicin—breast cancer	0.000106	0.000532	CcSEcCtD
Dimenhydrinate—Somnolence—Methotrexate—breast cancer	0.000106	0.00053	CcSEcCtD
Dimenhydrinate—Dizziness—Capecitabine—breast cancer	0.000106	0.000529	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—breast cancer	0.000105	0.000527	CcSEcCtD
Dimenhydrinate—Vomiting—Docetaxel—breast cancer	0.000105	0.000526	CcSEcCtD
Dimenhydrinate—Dyspepsia—Methotrexate—breast cancer	0.000105	0.000525	CcSEcCtD
Dimenhydrinate—Rash—Docetaxel—breast cancer	0.000104	0.000521	CcSEcCtD
Dimenhydrinate—Hypotension—Epirubicin—breast cancer	0.000104	0.000521	CcSEcCtD
Dimenhydrinate—Dermatitis—Docetaxel—breast cancer	0.000104	0.000521	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—breast cancer	0.000104	0.00052	CcSEcCtD
Dimenhydrinate—Decreased appetite—Methotrexate—breast cancer	0.000103	0.000518	CcSEcCtD
Dimenhydrinate—Headache—Docetaxel—breast cancer	0.000103	0.000518	CcSEcCtD
Dimenhydrinate—Fatigue—Methotrexate—breast cancer	0.000103	0.000514	CcSEcCtD
Dimenhydrinate—Vomiting—Capecitabine—breast cancer	0.000102	0.000509	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—breast cancer	0.000101	0.000505	CcSEcCtD
Dimenhydrinate—Rash—Capecitabine—breast cancer	0.000101	0.000505	CcSEcCtD
Dimenhydrinate—Insomnia—Epirubicin—breast cancer	0.000101	0.000505	CcSEcCtD
Dimenhydrinate—Dermatitis—Capecitabine—breast cancer	0.000101	0.000504	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—breast cancer	0.000101	0.000504	CcSEcCtD
Dimenhydrinate—Headache—Capecitabine—breast cancer	0.0001	0.000502	CcSEcCtD
Dimenhydrinate—Paraesthesia—Epirubicin—breast cancer	0.0001	0.000501	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—breast cancer	9.96e-05	0.000499	CcSEcCtD
Dimenhydrinate—Somnolence—Epirubicin—breast cancer	9.9e-05	0.000496	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—breast cancer	9.82e-05	0.000492	CcSEcCtD
Dimenhydrinate—Nausea—Docetaxel—breast cancer	9.81e-05	0.000491	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Methotrexate—breast cancer	9.8e-05	0.000491	CcSEcCtD
Dimenhydrinate—Dyspepsia—Epirubicin—breast cancer	9.8e-05	0.000491	CcSEcCtD
Dimenhydrinate—Decreased appetite—Epirubicin—breast cancer	9.68e-05	0.000485	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—breast cancer	9.63e-05	0.000482	CcSEcCtD
Dimenhydrinate—Fatigue—Epirubicin—breast cancer	9.6e-05	0.000481	CcSEcCtD
Dimenhydrinate—Constipation—Epirubicin—breast cancer	9.52e-05	0.000477	CcSEcCtD
Dimenhydrinate—Nausea—Capecitabine—breast cancer	9.49e-05	0.000476	CcSEcCtD
Dimenhydrinate—Modafinil—CYP3A4—breast cancer	9.49e-05	0.129	CrCbGaD
Dimenhydrinate—Urticaria—Methotrexate—breast cancer	9.45e-05	0.000474	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—breast cancer	9.32e-05	0.000467	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—breast cancer	9.25e-05	0.000463	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Epirubicin—breast cancer	9.18e-05	0.00046	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—breast cancer	9.16e-05	0.000459	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—breast cancer	9.07e-05	0.000454	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—breast cancer	8.96e-05	0.000449	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—breast cancer	8.88e-05	0.000445	CcSEcCtD
Dimenhydrinate—Urticaria—Epirubicin—breast cancer	8.85e-05	0.000443	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—breast cancer	8.81e-05	0.000441	CcSEcCtD
Dimenhydrinate—Asthenia—Methotrexate—breast cancer	8.54e-05	0.000428	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—breast cancer	8.49e-05	0.000425	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—breast cancer	8.18e-05	0.00041	CcSEcCtD
Dimenhydrinate—Diarrhoea—Methotrexate—breast cancer	8.14e-05	0.000408	CcSEcCtD
Dimenhydrinate—Asthenia—Epirubicin—breast cancer	7.99e-05	0.0004	CcSEcCtD
Dimenhydrinate—Dizziness—Methotrexate—breast cancer	7.87e-05	0.000394	CcSEcCtD
Dimenhydrinate—Diphenhydramine—CYP2D6—breast cancer	7.69e-05	0.105	CrCbGaD
Dimenhydrinate—Diarrhoea—Epirubicin—breast cancer	7.62e-05	0.000382	CcSEcCtD
Dimenhydrinate—Vomiting—Methotrexate—breast cancer	7.56e-05	0.000379	CcSEcCtD
Dimenhydrinate—Rash—Methotrexate—breast cancer	7.5e-05	0.000376	CcSEcCtD
Dimenhydrinate—Dermatitis—Methotrexate—breast cancer	7.49e-05	0.000375	CcSEcCtD
Dimenhydrinate—Headache—Methotrexate—breast cancer	7.45e-05	0.000373	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—breast cancer	7.39e-05	0.00037	CcSEcCtD
Dimenhydrinate—Dizziness—Epirubicin—breast cancer	7.36e-05	0.000369	CcSEcCtD
Dimenhydrinate—Vomiting—Epirubicin—breast cancer	7.08e-05	0.000355	CcSEcCtD
Dimenhydrinate—Nausea—Methotrexate—breast cancer	7.07e-05	0.000354	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—breast cancer	7.05e-05	0.000353	CcSEcCtD
Dimenhydrinate—Rash—Epirubicin—breast cancer	7.02e-05	0.000352	CcSEcCtD
Dimenhydrinate—Dermatitis—Epirubicin—breast cancer	7.01e-05	0.000351	CcSEcCtD
Dimenhydrinate—Headache—Epirubicin—breast cancer	6.98e-05	0.000349	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—breast cancer	6.81e-05	0.000341	CcSEcCtD
Dimenhydrinate—Nausea—Epirubicin—breast cancer	6.61e-05	0.000331	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—breast cancer	6.55e-05	0.000328	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—breast cancer	6.5e-05	0.000325	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—breast cancer	6.49e-05	0.000325	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—breast cancer	6.45e-05	0.000323	CcSEcCtD
Dimenhydrinate—Orphenadrine—CYP3A4—breast cancer	6.24e-05	0.0851	CrCbGaD
Dimenhydrinate—Nausea—Doxorubicin—breast cancer	6.12e-05	0.000307	CcSEcCtD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFC—breast cancer	2.43e-06	0.000721	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—WNT1—breast cancer	2.4e-06	0.000711	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JAG2—breast cancer	2.39e-06	0.00071	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	2.39e-06	0.00071	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CSF2—breast cancer	2.36e-06	0.000702	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—WNT1—breast cancer	2.36e-06	0.0007	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PLA2G4A—breast cancer	2.35e-06	0.000698	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CSF2—breast cancer	2.33e-06	0.000691	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH4—breast cancer	2.27e-06	0.000674	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GZMB—breast cancer	2.26e-06	0.00067	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH4—breast cancer	2.24e-06	0.000664	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GZMB—breast cancer	2.22e-06	0.000659	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCL2—breast cancer	2.19e-06	0.000651	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AGTR2—breast cancer	2.19e-06	0.000651	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—BMP2—breast cancer	2.17e-06	0.000643	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTHLH—breast cancer	2.17e-06	0.000643	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AGTR2—breast cancer	2.16e-06	0.00064	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCL2—breast cancer	2.16e-06	0.00064	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTHLH—breast cancer	2.13e-06	0.000633	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—BMP2—breast cancer	2.13e-06	0.000633	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EDNRB—breast cancer	2.1e-06	0.000623	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PGR—breast cancer	2.08e-06	0.000617	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—THBS1—breast cancer	2.07e-06	0.000614	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EDNRB—breast cancer	2.07e-06	0.000613	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PGR—breast cancer	2.05e-06	0.000607	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—THBS1—breast cancer	2.04e-06	0.000604	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FLT1—breast cancer	1.97e-06	0.000586	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF3—breast cancer	1.97e-06	0.000583	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SQSTM1—breast cancer	1.97e-06	0.000583	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	1.96e-06	0.00058	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FLT1—breast cancer	1.94e-06	0.000576	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—JAG1—breast cancer	1.94e-06	0.000576	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF3—breast cancer	1.93e-06	0.000574	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SQSTM1—breast cancer	1.93e-06	0.000574	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PARP1—breast cancer	1.93e-06	0.000573	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH3—breast cancer	1.93e-06	0.000573	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CG—breast cancer	1.92e-06	0.000571	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JAG1—breast cancer	1.91e-06	0.000567	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CALCA—breast cancer	1.91e-06	0.000566	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH3—breast cancer	1.9e-06	0.000564	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PARP1—breast cancer	1.9e-06	0.000564	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RPS6—breast cancer	1.89e-06	0.00056	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CALCA—breast cancer	1.88e-06	0.000557	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF4—breast cancer	1.87e-06	0.000555	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCL12—breast cancer	1.86e-06	0.000553	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCR4—breast cancer	1.86e-06	0.000553	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RPS6—breast cancer	1.86e-06	0.000551	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF4—breast cancer	1.84e-06	0.000546	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCR4—breast cancer	1.83e-06	0.000544	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCL12—breast cancer	1.83e-06	0.000544	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PAK1—breast cancer	1.83e-06	0.000543	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PAK1—breast cancer	1.8e-06	0.000534	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TCF7L2—breast cancer	1.8e-06	0.000533	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT2—breast cancer	1.79e-06	0.000531	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CG—breast cancer	1.78e-06	0.000527	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TCF7L2—breast cancer	1.77e-06	0.000525	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT2—breast cancer	1.76e-06	0.000522	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CG—breast cancer	1.75e-06	0.000519	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH2—breast cancer	1.73e-06	0.000514	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HSP90AA1—breast cancer	1.73e-06	0.000514	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	1.72e-06	0.00051	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HSP90AA1—breast cancer	1.71e-06	0.000506	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH2—breast cancer	1.71e-06	0.000506	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CD—breast cancer	1.69e-06	0.000502	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AGTR1—breast cancer	1.69e-06	0.0005	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRL—breast cancer	1.69e-06	0.0005	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STK11—breast cancer	1.66e-06	0.000493	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADAM10—breast cancer	1.66e-06	0.000493	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AGTR1—breast cancer	1.66e-06	0.000492	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRL—breast cancer	1.66e-06	0.000492	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PLG—breast cancer	1.64e-06	0.000488	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADAM10—breast cancer	1.64e-06	0.000485	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STK11—breast cancer	1.64e-06	0.000485	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT2—breast cancer	1.62e-06	0.000482	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PLG—breast cancer	1.62e-06	0.00048	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF10—breast cancer	1.62e-06	0.00048	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT2—breast cancer	1.6e-06	0.000474	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF10—breast cancer	1.59e-06	0.000472	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CD—breast cancer	1.56e-06	0.000463	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PDGFA—breast cancer	1.56e-06	0.000463	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TGFBR2—breast cancer	1.54e-06	0.000456	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CD—breast cancer	1.54e-06	0.000456	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PDGFA—breast cancer	1.53e-06	0.000455	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ITPR1—breast cancer	1.51e-06	0.000449	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TGFBR2—breast cancer	1.51e-06	0.000449	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT5A—breast cancer	1.5e-06	0.000446	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ERBB4—breast cancer	1.5e-06	0.000446	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MMP3—breast cancer	1.5e-06	0.000446	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	1.5e-06	0.000445	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ITPR1—breast cancer	1.49e-06	0.000442	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ERBB4—breast cancer	1.48e-06	0.000439	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT5A—breast cancer	1.48e-06	0.000439	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MMP3—breast cancer	1.48e-06	0.000439	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	1.47e-06	0.000438	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SMAD4—breast cancer	1.46e-06	0.000432	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IGF1R—breast cancer	1.45e-06	0.000429	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CXCL8—breast cancer	1.44e-06	0.000427	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SMAD4—breast cancer	1.43e-06	0.000425	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IGF1R—breast cancer	1.42e-06	0.000422	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HES1—breast cancer	1.42e-06	0.000422	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	1.42e-06	0.00042	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NCOR1—breast cancer	1.41e-06	0.000419	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PLA2G4A—breast cancer	1.41e-06	0.000419	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HES1—breast cancer	1.4e-06	0.000415	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CSF2—breast cancer	1.4e-06	0.000415	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF1—breast cancer	1.4e-06	0.000415	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—RAF1—breast cancer	1.39e-06	0.000414	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	1.39e-06	0.000413	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NCOR1—breast cancer	1.39e-06	0.000413	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NRG1—breast cancer	1.39e-06	0.000412	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—H2AFX—breast cancer	1.38e-06	0.000409	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—IL2—breast cancer	1.38e-06	0.000408	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF1—breast cancer	1.37e-06	0.000408	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CSF2—breast cancer	1.37e-06	0.000408	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—RAF1—breast cancer	1.37e-06	0.000407	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—E2F1—breast cancer	1.37e-06	0.000406	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NRG1—breast cancer	1.36e-06	0.000405	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CB—breast cancer	1.36e-06	0.000404	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—H2AFX—breast cancer	1.35e-06	0.000402	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—IL2—breast cancer	1.35e-06	0.000402	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—E2F1—breast cancer	1.35e-06	0.000399	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	1.34e-06	0.000397	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SPP1—breast cancer	1.31e-06	0.00039	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CXCL8—breast cancer	1.31e-06	0.000388	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ERBB3—breast cancer	1.3e-06	0.000386	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGFR2—breast cancer	1.3e-06	0.000385	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SPP1—breast cancer	1.29e-06	0.000384	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CXCL8—breast cancer	1.29e-06	0.000382	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ERBB3—breast cancer	1.28e-06	0.000379	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGFR2—breast cancer	1.28e-06	0.000379	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL2—breast cancer	1.25e-06	0.000371	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TERT—breast cancer	1.25e-06	0.00037	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL2—breast cancer	1.23e-06	0.000365	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TERT—breast cancer	1.23e-06	0.000364	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGFR1—breast cancer	1.21e-06	0.000359	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HIF1A—breast cancer	1.19e-06	0.000353	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGFR1—breast cancer	1.19e-06	0.000353	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HIF1A—breast cancer	1.17e-06	0.000348	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—LEP—breast cancer	1.16e-06	0.000345	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CAV1—breast cancer	1.15e-06	0.000342	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—LEP—breast cancer	1.14e-06	0.000339	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KDR—breast cancer	1.14e-06	0.000338	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CAV1—breast cancer	1.13e-06	0.000336	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KDR—breast cancer	1.12e-06	0.000333	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ESR1—breast cancer	1.11e-06	0.000329	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FN1—breast cancer	1.1e-06	0.000325	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ESR1—breast cancer	1.09e-06	0.000324	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NFKBIA—breast cancer	1.08e-06	0.000321	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FN1—breast cancer	1.08e-06	0.00032	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH1—breast cancer	1.07e-06	0.000318	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NFKBIA—breast cancer	1.07e-06	0.000316	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH1—breast cancer	1.06e-06	0.000313	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CG—breast cancer	1.05e-06	0.000311	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—APC—breast cancer	1.05e-06	0.000311	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KIT—breast cancer	1.05e-06	0.000311	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EGF—breast cancer	1.04e-06	0.000308	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CG—breast cancer	1.03e-06	0.000306	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KIT—breast cancer	1.03e-06	0.000306	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—APC—breast cancer	1.03e-06	0.000306	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EGF—breast cancer	1.02e-06	0.000303	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAPK3—breast cancer	1e-06	0.000298	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAPK3—breast cancer	9.89e-07	0.000293	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—BRAF—breast cancer	9.86e-07	0.000293	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—BRAF—breast cancer	9.7e-07	0.000288	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IGF1—breast cancer	9.61e-07	0.000285	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT2—breast cancer	9.6e-07	0.000285	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EGFR—breast cancer	9.56e-07	0.000284	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IGF1—breast cancer	9.45e-07	0.00028	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT2—breast cancer	9.44e-07	0.00028	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EGFR—breast cancer	9.4e-07	0.000279	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CD—breast cancer	9.22e-07	0.000274	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	9.14e-07	0.000271	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SERPINE1—breast cancer	9.12e-07	0.000271	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CD—breast cancer	9.07e-07	0.000269	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—KRAS—breast cancer	9.03e-07	0.000268	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	8.99e-07	0.000267	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SERPINE1—breast cancer	8.98e-07	0.000266	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—KRAS—breast cancer	8.88e-07	0.000264	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOS3—breast cancer	8.71e-07	0.000258	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOS3—breast cancer	8.57e-07	0.000254	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CA—breast cancer	8.3e-07	0.000246	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MDM2—breast cancer	8.26e-07	0.000245	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RAF1—breast cancer	8.23e-07	0.000244	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RELA—breast cancer	8.2e-07	0.000243	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	8.16e-07	0.000242	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ERBB2—breast cancer	8.15e-07	0.000242	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MDM2—breast cancer	8.13e-07	0.000241	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RAF1—breast cancer	8.1e-07	0.00024	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RELA—breast cancer	8.07e-07	0.000239	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CB—breast cancer	8.04e-07	0.000239	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MTOR—breast cancer	8.04e-07	0.000239	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ERBB2—breast cancer	8.02e-07	0.000238	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CB—breast cancer	7.91e-07	0.000235	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MTOR—breast cancer	7.91e-07	0.000235	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCL8—breast cancer	7.72e-07	0.000229	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HRAS—breast cancer	7.67e-07	0.000228	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCL8—breast cancer	7.6e-07	0.000226	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HRAS—breast cancer	7.55e-07	0.000224	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN1B—breast cancer	7.54e-07	0.000224	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT1—breast cancer	7.46e-07	0.000221	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN1B—breast cancer	7.42e-07	0.00022	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CASP3—breast cancer	7.39e-07	0.000219	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL2—breast cancer	7.38e-07	0.000219	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6—breast cancer	7.35e-07	0.000218	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT1—breast cancer	7.34e-07	0.000218	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CASP3—breast cancer	7.28e-07	0.000216	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL2—breast cancer	7.26e-07	0.000216	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6—breast cancer	7.23e-07	0.000214	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCND1—breast cancer	7.2e-07	0.000214	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—JUN—breast cancer	7.18e-07	0.000213	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CTNNB1—breast cancer	7.13e-07	0.000211	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCND1—breast cancer	7.08e-07	0.00021	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JUN—breast cancer	7.07e-07	0.00021	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CTNNB1—breast cancer	7.01e-07	0.000208	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MMP9—breast cancer	6.99e-07	0.000207	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN1A—breast cancer	6.96e-07	0.000207	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTEN—breast cancer	6.95e-07	0.000206	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MMP9—breast cancer	6.88e-07	0.000204	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN1A—breast cancer	6.85e-07	0.000203	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTEN—breast cancer	6.84e-07	0.000203	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK8—breast cancer	6.8e-07	0.000202	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT1—breast cancer	6.78e-07	0.000201	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK8—breast cancer	6.69e-07	0.000198	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT1—breast cancer	6.67e-07	0.000198	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SRC—breast cancer	6.44e-07	0.000191	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SRC—breast cancer	6.34e-07	0.000188	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—VEGFA—breast cancer	6.27e-07	0.000186	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT3—breast cancer	6.21e-07	0.000184	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFA—breast cancer	6.17e-07	0.000183	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT3—breast cancer	6.11e-07	0.000181	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK3—breast cancer	5.94e-07	0.000176	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK3—breast cancer	5.84e-07	0.000173	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MYC—breast cancer	5.77e-07	0.000171	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TGFB1—breast cancer	5.76e-07	0.000171	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MYC—breast cancer	5.68e-07	0.000169	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TGFB1—breast cancer	5.67e-07	0.000168	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EGFR—breast cancer	5.65e-07	0.000168	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EGFR—breast cancer	5.56e-07	0.000165	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KRAS—breast cancer	5.33e-07	0.000158	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KRAS—breast cancer	5.25e-07	0.000156	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CA—breast cancer	4.9e-07	0.000145	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CA—breast cancer	4.82e-07	0.000143	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TP53—breast cancer	4.74e-07	0.000141	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TP53—breast cancer	4.66e-07	0.000138	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HRAS—breast cancer	4.53e-07	0.000135	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HRAS—breast cancer	4.46e-07	0.000132	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6—breast cancer	4.34e-07	0.000129	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6—breast cancer	4.27e-07	0.000127	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT1—breast cancer	4e-07	0.000119	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT1—breast cancer	3.94e-07	0.000117	CbGpPWpGaD
